- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NTLA
Recent news which mentions NTLA
2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street
February 24, 2025
From Motley Fool
This RingCentral Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
January 27, 2025
From Benzinga
From Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
January 22, 2025
From Benzinga
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
January 22, 2025
From Benzinga
13 Analysts Have This To Say About Intellia Therapeutics
January 13, 2025
Tickers
NTLA
From Benzinga
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
January 11, 2025
From Benzinga
Peering Into Intellia Therapeutics's Recent Short Interest
January 10, 2025
Tickers
NTLA
From Benzinga
Why Is Intellia Therapeutics Stock Trading Lower On Friday?
January 10, 2025
From Benzinga
Peering Into Intellia Therapeutics's Recent Short Interest
December 24, 2024
Tickers
NTLA
From Benzinga
From Benzinga
Tickers
NTLA
From Motley Fool
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
November 18, 2024
From Benzinga
9 Analysts Have This To Say About Intellia Therapeutics
November 11, 2024
Tickers
NTLA
From Benzinga
A Glimpse of Intellia Therapeutics's Earnings Potential
November 06, 2024
Tickers
NTLA
From Benzinga
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
November 06, 2024
Tickers
NTLA
From Motley Fool
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
November 04, 2024
Tickers
NTLA
From Motley Fool
Looking Into Intellia Therapeutics's Recent Short Interest
October 29, 2024
Tickers
NTLA
From Benzinga
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
From Motley Fool
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 24, 2024
From Benzinga
Why Intellia Therapeutics Stock Plummeted by 20% Today
October 24, 2024
Tickers
NTLA
From Motley Fool
A Closer Look at Intellia Therapeutics's Options Market Dynamics
October 24, 2024
Tickers
NTLA
From Benzinga
From Benzinga
3 Health Care Stocks Moving In Thursday's Intraday Session
October 24, 2024
From Benzinga
Tickers
NTLA
From Motley Fool
From Motley Fool
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
September 29, 2024
From Motley Fool
Expert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts
September 11, 2024
Tickers
NTLA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.